Peptides and physical therapy Physical therapy remains foundational for back pain regardless of peptide use
This typically involves: Intrinsic factor antibodies (highly specific for pernicious anaemia, though sensitivity is only 50%) [12] [28] Gastric parietal cell antibodies (more sensitive but less specific) Coeliac serology if malabsorption is suspected Consideration of upper gastrointestinal endoscopy in selected cases, particularly with autoimmune gastritis/pernicious anaemia NICE guidance emphasises that treatment should not be delayed whilst awaiting antibody results if clinical features strongly suggest deficiency, as irreversible neurological damage can occur
Chemical name: Pentadecapeptide BPC-157 (Body Protection Compound-157) Synonyms: BPC157
Consumer-facing claims about BPC-157 efficacy in humans for tendinopathy, joint pain, gastrointestinal disorders, or neurological conditions therefore extrapolate from rat and HUVEC work and are not supported by controlled human evidence
Thats what makes it readily available via telehealth providers like AgelessRx and Shed, whereas peptides like Ipamorelin which were never FDA-approved lack that pathway and face greater regulatory restrictions
